Kent J. Weinhold - Concepedia

Author

Kent J. Weinhold

Also Known As

Ganusov, Vitaly, Hahn, Beatrice H., Hawkins, Natalie, K J WEINHOLD, K J Weinhold, K Weinhold, K. J. Weinhold, K. Weinhold, K.J. WEINHOLD, K.J. Weinhold

295

Publications

15.3K

Citations

H-Index

135

Concepts

All Affiliations

Duke Medical Center Duke University Duke University Hospital University of Alabama at Birmingham Johns Hopkins University

About

Kent J. Weinhold is an author at Duke Medical Center specializing in medicine, immunology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	65	7.7K
2	Allergy	9	9	3K
3	Health Sciences	3	3	58
4	Natural Sciences	3	3	1.7K
5	Engineering	2	2	71

Kent J. Weinhold

136

Publications

14.7K

Citations

H-Index

Page 1

	Year	Citations
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Hiroaki Mitsuya, Kent J. Weinhold, P A Furman, Proceedings of the National Academy of Sciences ImmunologyBw A509uCytopathic EffectAntiviral DrugImmunotherapy	1985	1.8K
Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. P A Furman, James A. Fyfe, M H St Clair, Proceedings of the National Academy of Sciences Viral ReplicationThymidine AnalogImmunologyMolecular BiologyAntiviral Drug	1986	1.3K
Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing Determinant Gregory J. LaRosa, Joseph P. Davide, Kent J. Weinhold, Science	1990	654
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection Nilu Goonetilleke, Michael K. P. Liu, Jesus F. Salazar-Gonzalez, The Journal of Experimental Medicine	2009	636
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia Georgia D. Tomaras, Nicole L. Yates, Pinghuang Liu, Journal of Virology ImmunologyViral DynamicPlasma VirusImmunotherapyViral Persistence	2008	618
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma Karolina Woroniecka, Pakawat Chongsathidkiet, Kristen E. Rhodin, Clinical Cancer Research	2018	610
HTLV-III/LAV-Neutralizing Antibodies to an <i>E. coli</i> -Produced Fragment of the Virus Envelope Scott D. Putney, Thomas J. Matthews, W. Gerard Robey, Science	1986	332
A Controlled Trial of Early versus Late Treatment with Zidovudine in Symptomatic Human Immunodeficiency Virus Infection John D. Hamilton, Pamela Hartigan, Michael S. Simberkoff, New England Journal of Medicine	1992	329
3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase M H St Clair, C A Richards, T Spector, Antimicrobial Agents and Chemotherapy ImmunologyMolecular BiologyAntiviral DrugChemical BiologyMedicinal Chemistry	1987	279
Standardization of cytokine flow cytometry assays Holden T. Maecker, Aline Rinfret, Patricia D’Souza, BMC Immunology	2005	238

Page 1